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a b s t r a c t
The bovine herpes virus 1 (BoHV-1) encoded latency-related RNA (LR-RNA) is abundantly expressed in
latently infected sensory neurons. A LR mutant virus with three stop codons at the amino-terminus of
ORF2 does not reactivate from latency or replicate efﬁciently in certain tissues. ORF2 inhibits apoptosis,
interacts with Notch1 or Notch3, and interferes with Notch mediated signaling. Alternative splicing of
LR-RNA in trigeminal ganglia yields transcripts that have the potential to encode a protein containing
most of ORF2 sequences and parts of other coding sequences located within the LR gene. In this study,
we determined that an ORF2 protein fused with reading frame B (15d ORF) was more stable in
transfected cells. ORF2 and the 15d ORF stimulated neurite formation in mouse neuroblastoma cells,
interfered with Notch3 mediated trans-activation, and had similar DNA binding properties. Increased
stability of the 15d ORF is predicted to enhance the establishment of latency.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Bovine herpesvirus 1 (BoHV-1), an alpha-herpesvirinae sub-
family member, causes signiﬁcant economic losses to the cattle
industry (Turin et al., 1999; Jones, 2009; Jones and Chowdhury,
2007). When acute infection occurs on mucosal linings within the
ocular, nasal, or oral cavity, sensory neurons within trigeminal
ganglia (TG) become the primary site for BoHV-1 latency. Abun-
dant viral gene expression (Schang and Jones, 1997) and infectious
virus (Inman et al., 2002) are detected during acute infection, but
once latency is established and infectious virus is not readily
detected (Jones et al., 2006; Jones and Chowdhury, 2007). Stress
increases corticosteroid levels, and initiates reactivation from
latency, which is crucial for virus transmission (Jones and
Chowdhury, 2010). Administration of the synthetic corticosteroid
dexamethasone to calves latently infected with BoHV-1 reprodu-
cibly induces reactivation from latency (Inman et al., 2002; Jones,
1998, 2003; Jones et al., 2006, 2000; Rock et al., 1992). Within
90 min after dexamethasone treatment, certain cellular transcrip-
tion factors that stimulate productive infection and viral promo-
ters are readily detected in trigeminal ganglionic sensory neurons
(Workman
et al., 2012). Dexamethasone also induces expression of two viral
proteins, bICP0 and VP16, in sensory neurons of latently infected
calves within 90 min after treatment (Frizzo da Silva et al., 2013).
We suggest that increased corticosteroids, as a result of stress,
stimulate lytic cycle viral gene expression by several distinct
mechanisms: consequently reactivation from latency occurs.
The BoHV-1 encoded latency related (LR) RNA is abundantly
expressed in latently infected neurons (Jones, 1998, 2003; Jones
et al., 2006; Kutish et al., 1990; Rock et al., 1992; Rock et al., 1987).
LR-RNA is anti-sense relative to the bICP0 gene and has a unique
start site in TG (Bratanich et al., 1992; Hossain et al., 1995). Two
open reading frames (ORF1 and ORF2) and two reading frames
that lack an initiating ATG (RF-B and RF-C) are present in the LR
gene (Kutish et al., 1990) (Fig. 1A). An LR mutant virus strain with
3 stop codons at the N-terminus of ORF2 exhibits diminished
clinical symptoms, and reduced virus shedding from the eye, TG,
or tonsils of infected calves (Inman et al., 2001b). Furthermore,
the LR mutant virus does not reactivate from latency following
dexamethasone treatment, in part because establishment of
latency is reduced (Inman et al., 2002). ORF2 containing proteins
promotes cell survival by inhibiting apoptosis (Ciacci-Zanella et al.,
1999; Lovato et al., 2003; Shen and Jones, 2008; Sinani and Jones,
2011), which we predict is important for the latency-reactivation
cycle. ORF2 also interacts with cellular transcription factors,
Notch1, Notch3, or C/EBP-α (Meyer et al., 2007a,b; Meyer and
Jones, 2008; Workman et al., 2011) and reduce Notch mediated
trans-activation of the bICP0 early promoter and glycoprotein C
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Fig. 1. Schematic of LR gene and comparison of ORF2 versus 15d ORF. Panel A: Location of ORFs within the LR gene. The numbering system of the LR gene and position of
ORF2 was derived from a previous study (Kutish et al., 1990). Reading frames that lack an initiating methionine are designated RF-B and RF-C. LR ORF1, ORF2, and RF-C are
located in reading frames a–c respectively. RF-B, like ORF2, is in reading frame b. The 15d ORF is comprised of ORF2 sequences and contains 36 amino acids derived from RF-B
due to alternative splicing (Devireddy and Jones, 1998). Panel B: Comparison of ORF2 amino acid sequences versus the 15 d ORF. Amino acid sequence of ORF2 and 15 cDNA
ORF: dashed lines in 15d ORF reﬂect identity with ORF2. The black shaded amino acids in ORF2 and the 15d ORF are basic amino acids, the underlined amino acids are the
nuclear localization sequence, and the gray shaded amino acids are protein kinase A or protein kinase C phosphorylation sites. The 36 gray amino acids in the 15d ORF are
from C-terminal sequences of RF-B. Consequently, the 15d ORF has no serine or threonine residues at its C-terminus: but it contains an additional tyrosine residue. The
C-terminal ORF2 sequences have one threonine (PKA), one serine, and no tyrosine residues. The 15d ORF sequences contain 9 basic amino acids whereas ORF2 has 10 basic
amino acids (shaded in gray) in the same domain, which results in a slight charge difference between the two isoforms. Theþsign denotes every 10th amino acid. The
location of peptides used to generate the P2 and ORF2 polyclonal antibody are denoted. Panel C: Neuro-2A cells were transfected with 2 μg of the designated plasmids that
express a Flag-tagged ORF2 or 15d ORF. 48h after transfection total lysate was prepared and Western blot analysis performed using the ORF2 polyclonal antibody (1:2000
dilution): 100 μg total cell lysate was used for each lane. Molecular weight markers are denoted to the right and the closed circle denotes the position of ORF2 and the 15d
ORF. Tubulin protein expression was used as a loading control for this study. The images are representative of 4 experiments. Panel D: Neuro-2A cells were transfected with
2 μg of the designated plasmids that express a Flag-tagged ORF2, 15d ORF, or the empty vector. Cultures were prepared for confocal microscopy at 48 h after transfection as
described in the materials and methods. Cells expressing ORF2 were stained with the anti-Flag antibody (red), ORF2 polyclonal antibody (green), or DAPI (blue) to visualize
ORF2 in the nucleus. Images are representative of 3 experiments.
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promoter. An abundant spliced poly-AþLR-RNA was identiﬁed in
TG of infected calves at 15 days post infection (dpi) and this cDNA
was sequenced (Devireddy and Jones, 1998). As a result of splicing,
the C-terminal sequences of ORF2 contain 36 amino acids derived
from RF-B that replace the C-terminal 32 amino acids of ORF2
(Fig. 1B and C). We propose that LR gene products promote the
establishment and maintenance of latency: but does not directly
inﬂuence reactivation from latency because all LR gene products
are repressed during the early stages of dexamethasone induced
reactivation from latency (Jaber et al., 2010; Rock et al., 1992;
Sinani et al., 2013).
In this study, we examined the properties of the 15d ORF to
known functions of ORF2. We found that the 15d ORF was more
stable than ORF2 in transfected Neuro-2A cells. As with ORF2,
the 15d ORF localized to the nuclear periphery, interfered
with Notch3-mediated trans-activation, re-localized Notch3 to
the nuclear periphery, and stably interacted with DNA. We suggest
that the enhanced stability of the 15d ORF is important during the
establishment of latency.
Results
The 15 dpi cDNA has the potential to encode a protein fusing ORF2
with the C-terminus of RF-B
ORF2 is the ﬁrst open reading frame downstream of the start
site of LR-RNA (Fig. 1A) and ORF2 coding sequences completely
overlap the bICP0 transcript (Rock et al., 1987). ORF2 is expressed
in a subset of latently infected neurons (Jiang et al., 1998; Jones
et al., 2011; Sinani et al., 2013) and its expression appears to be
important for dexamethasone induced reactivation from latency
and viral replication in the ocular cavity, tonsil, and TG (Inman
et al., 2001a, 2002). We originally designed a peptide antibody
(P2) that recognized a prominent 40 kd protein and several other
proteins, including a 20–25 kd protein (Hossain et al., 1995), which
is the approximate size of ORF2 (Rock et al., 1987) (see Fig. 1B for
location of P2 peptide). We assumed that the 40 kd protein was a
large protein comprised of ORF2, and as a result of splicing, one of
the adjacent reading frames or ORF1 comprised the C-terminal
part of this large protein. In trigeminal ganglia at 7 days after
infection (dpi), an alternatively spliced LR transcript was discov-
ered that has the potential to encode a protein comprised of ORF2
and ORF1 sequences (Devireddy et al., 2003; Devireddy and Jones,
1998). However, the major spliced LR-RNA identiﬁed in TG of cattle
at 1 and 60 dpi has the potential to encode the intact ORF2
(Devireddy and Jones, 1998). Since ORF2 can inhibit apoptosis and
interacts with Notch1 and Notch3 in the absence of other viral
genes (Shen and Jones, 2008; Sinani and Jones, 2011; Workman
et al., 2011), we have focused our studies on ORF2. Two immuno-
dominant peptides were used to generate an additional ORF2
polyclonal antibody (for locations of ORF2 peptides, see Fig. 1B).
The ORF2 polyclonal antibody recognized a protein migrating at
approximately 21 kd following transfection of Neuro-2A cells with
the ORF2 expression vector, but this band was absent in cells
transfected with the empty vector (Fig. 1C). This result is consis-
tent with that obtained with the Flag antibody (for example, see
Fig. 2B). Furthermore, the ORF2 polyclonal antibody and Flag
antibody recognized a protein that localized to the nuclear
periphery in Neuro-2A cells when transfected with the ORF2
expression vector; conversely neither antibody recognized a pro-
tein in cells transfected with the empty vector (Fig. 1D).
A spliced polyAþLR-RNA in TG of calves, which is readily
detected at 15 days after infection, has the potential to be
translated into a protein that contains the last 36 amino acids of
RF-B in place of the last 32 amino acids of ORF2 (Devireddy and
Jones, 1998) (Fig. 1A and B; designated as the 15d ORF). The
nuclear localization signal (NLS) within ORF2 and the 15d ORF
(Fig. 1B) are identical to the NLS in the transcription factor Sp1
(Devireddy et al., 2003) and deletion of amino acids comprising
the ORF2 NLS prevents nuclear localization (Sinani and Jones,
2011). ORF2 contains approximately 18% basic amino acids (Fig. 1B,
black shaded amino acids). The 15d ORF contains one less basic
amino acid, lacks a consensus protein kinase C (PKC)/PKA phos-
phorylation site at amino acid 174, and contains a novel tyrosine
residue near the C-terminus. The Flag (Fig. 2D) and ORF2 poly-
clonal antibody (Fig. 1C) recognize a protein migrating near 20 kd.
Relative to ORF2, the ORF2 polyclonal did not recognize the 15d
ORF as well as ORF2 because the C-terminal immuno-dominant
peptide used to generate the ORF2 polyclonal antibody is missing
in the 15d ORF (Fig. 1B).
A panel of transposon insertion mutants spanning the 15d ORF
was constructed to identify functional domains (see Fig. 2A for
location of transposon insertions). The 15d ORF contains four
consensus protein kinase A (PKA) and PKC phosphorylation sites
(Fig. 1B; gray shaded amino acids). Activation of PKA stimulates
HSV-1 reactivation from latency (Leib et al., 1991; Smith et al.,
1992) suggesting PKA regulates certain functions of ORF2 or the
15d ORF. To test whether the consensus phosphorylation sites
within the 15d ORF mutant are important, a mutant was prepared
in which the serine or threonine residues in PKA/PKC consensus
sites were substituted with alanine (15d-P). This mutant also
contains alanine substitutions at Tyr39 and Ser120 because they
are adjacent to the PKA/PKC sites.
Relative to the 15d ORF (Fig. 2B), reduced levels of the 20 kd
protein was consistently detected in Neuro-2A cells transfected with
the following transposon mutants, 15d-119, -159, -169, -524, and
-525. As previously reported (Pittayakhajonwut et al., 2013; Sinani
and Jones, 2011), the ORF2 mutant containing alanine substitutions
in the PKA/PKC consensus motifs was expressed at higher levels
compared to wt ORF2 (Fig. 2C). The 15d-P mutant was only
expressed at a slightly higher steady state level relative to the 15d
ORF (arrow) (Fig. 2D). The predominant band expressed by ORF2-P
and the 15d-P mutant migrated as a slightly larger molecular weight
compared to wt ORF2 or 15d ORF. The 15d ORF and all of the mutants
constructed were generally localized to the nuclear periphery in
transfected Neuro-2A cells (data not shown).
Neuro-2A cells transfected with the respective constructs were
treated with cycloheximide (CHX) to examine the stability of the
respective proteins in the absence of de novo protein synthesis.
We have consistently observed that ORF2 was not as stable as the
15d ORF (Fig. 2E and F). The ORF2-P mutant appeared to be as
stable as the 15d ORF, whereas the 15d-P mutant was not as stable.
These studies revealed three important differences: 1) the C-
terminal 36 amino acids within the 15d ORF increased the ½ life
of the protein in transfected cells, 2) ORF2 C-terminal sequences
decrease the ½ life of the protein, and 3) the missing PKA/PKC
phosphorylation site in the 15d ORF appeared to stabilize protein
expression in transiently transfected Neuro-2A cells.
The 15d ORF promotes neurite formation in Neuro-2A cells but
interferes with Notch3 mediated trans-activation
To understand whether the 15d ORF and ORF2 have similar
biological properties, we compared the ability of ORF2 to induce
neurite formation in Neuro-2A cells expressing Notch3 to the 15d
ORF. ORF2 promotes neurite formation in Neuro-2A cells over-
expressing activated Notch1 or Notch3 intracellular domain (ICD)
(Sinani et al., 2013), which correlates with the ability of ORF2 to
bind Notch1 or Notch3 and interfere with Notch-mediated trans-
activation of certain viral promoters (Workman et al., 2011). Notch
expression maintains neuronal progenitors in an undifferentiated
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state (Hitoshi et al., 2002). Activation of Notch signaling in
differentiated neurons inhibits neurite sprouting (Berezovska
et al., 1999; Franklin et al., 1999; Levy et al., 2002a,b; Sestan
et al., 1999) and axon repair (El Bejjani and Hammerlund, 2012),
which can result in neuronal cell death (Coleman and Freeman,
2010; Raff et al., 2002). The 15d ORF restored neurite formation in
Neuro-2A cells when cotransfected with Notch3 ICD and then
growth factors removed (Fig. 3A). As previously demonstrated
(Sinani et al., 2013), ORF2 also restored neurite formation, but
Neuro-2A cells transfected with Notch3 ICD plus the empty vector
did not routinely sprout long neurites. Quantiﬁcation of the data
revealed that ORF2 and the 15d ORF stimulated neurite formation
with similar efﬁciency (Fig. 3B).
Additional studies tested whether the 15d ORF inhibited trans-
activation of the Hairy Enhancer of Split 5 (HES5) promoter with
similar efﬁciency as ORF2. Hes5 protein expression is activated by
Notch signaling and the Hes5 protein inhibits neuronal differen-
tiation (Ohtsuka et al., 1999). The 15d ORF signiﬁcantly inhibited
the ability of the Notch3 ICD to trans-activate the HES5 promoter
in Neuro-2A cells (Fig. 4A). ORF2 and the 15d ORF inhibited Notch3
ICD mediated trans-activation of the HES5 promoter with similar
efﬁciency. Five of the nine-transposon mutants (15d-119, -159,
-235, -396, and -525) were unable to signiﬁcantly reduce Notch3
ICD mediated trans-activation of the HES5 promoter (Fig. 4B).
The 15d-P mutant inhibited Notch3 ICD mediated trans-activation
of the HES5 promoter to the same extent as the 15d ORF.
When the Notch3 ICD is expressed in Neuro-2A cells, it
localizes throughout the nucleus {Fig. 5A and Workman et al.,
(2011)}. Re-localization of the Notch3 ICD to the nuclear periphery
occurs in Neuro-2A cells that express ORF2 Workman et al., (2011)
and Fig. 5B}. We have consistently observed that the 15d ORF also
re-localized Notch3 ICD to the nuclear periphery in Neuro-2A cells
(Fig. 5C). In summary, the 15d ORF stimulated neurite formation in
cells expressing Notch3, inhibited Notch3 ICD mediated trans-
activation of the HES5 promoter and re-localized the Notch3 ICD
to the nuclear periphery in a similar fashion as ORF2.
The 15d ORF interacts with DNA
Studies were performed to compare the ability of the 15d ORF
versus ORF2 to interact with single stranded (ss)-DNA or double
stranded (ds)-DNA coupled to cellulose. The rationale for testing
ss- and ds-DNA is certain DNA binding proteins preferentially bind
ss- versus ds-DNA, reviewed in (Marceau, 2012) and ORF2 pre-
ferentially interacts with ss-DNA (Pittayakhajonwut et al., 2013).
Since the ORF2-P mutant was expressed at higher levels in
transfected cells compared to the 15d-P mutant or the 15d ORF,
we adjusted the levels of cell lysate to ensure that similar levels of
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Fig. 2. Expression of the 15d ORF and the mutants in transfected Neuro-2A cells. Panel A: Location of transposon mutants in the 15d ORF. Vertical lines with the respective
numbers indicate the nucleotide position of the respective transposon insertion. The position of the NLS, which spans nucleotides 192–210 (amino acids 64–70), is denoted
by the checkered rectangle. Panel B: Neuro-2A cells were transfected with plasmids expressing ORF2, the 15d ORF, or the respective mutant constructs. At 48 h after
transfection, cells were collected and processed for Western blot analysis as described in the materials and methods. 100 μg of protein was loaded in each lane. β-actin
protein expression was used as a loading control. An arrow denotes the position of wt ORF2, the 15d ORF, or the designated mutants. Panel C: Relative levels of wt ORF2
versus ORF2-P mutant in transfected Neuro-2A cells. 100 μg protein of total cell lysate in each lane. Tubulin protein expression was used as a loading control for this study.
Panel D: Relative levels of the 15d ORF versus the 15d-P mutant in transfected Neuro-2A cells. 100 μg protein of total cell lysate in each lane. Tubulin protein expression was
used as a loading control for this study. Panel E: Neuro-2A cells were transfected with either the ORF2 expression plasmid or the ORF2-P mutant. At 24 h after transfection,
cycloheximide (CHX; 100 μg/ml ﬁnal concentration) was added to cultures for the indicated time. Cell lysate (40 μg for ORF2-P and 120 μg for ORF2 protein) was examined
for ORF2 protein expression. Tubulin protein expression was used as a loading control for this study. Panel F: Neuro-2A cells were transfected with either the 15d ORF
expression plasmid or the 15d-P mutant. At 40 h after transfection, cycloheximide (CHX; 100 μg/ml ﬁnal concentration) was added to cultures for the indicated time.
Cell lysate (40 μg for 15d-P or 120 μg for 15d ORF protein) was then examined for ORF2 protein expression. Tubulin protein expression was used as a loading control for
this study.
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the respective ORF2 proteins were present in the DNA binding
assays. Cell lysate was incubated with DNA cellulose beads, and
binding of the 15d ORF or ORF2 to DNA cellulose beads was
detected by Western blot analysis using a Flag speciﬁc monoclonal
antibody. In ﬁve independent studies, the 15d ORF prepared from
transfected Neuro-2A cells preferentially interacted with ss-DNA,
which was similar to previous results for ORF2 (Fig. 6A). The 15d-P
mutant also interacted with ss-DNA and ds-DNA beads (Fig. 6B).
As a control, we examined the interaction between the ORF2-P
mutant because it is expressed at high levels in transfected Neuro-
2A cells and it binds preferentially to ds-DNA coupled to cellulose
(Pittayakhajonwut et al., 2013). The ORF2-P mutant showed a slight
preference for ds-DNA compared to ss-DNA (Fig. 6C), which was
similar to previous studies (Pittayakhajonwut et al., 2013). In
summary, these studies indicated that the 15d ORF interacted with
DNA coupled to cellulose, and suggested that the 15d-P mutant did
not interact with ds-DNA as efﬁciently as the ORF2-P mutant.
Discussion
In this study, we compared a novel protein, the 15d ORF
to ORF2, which is generated by alternative splicing of poly-Aþ
LR-RNA in TG (Devireddy and Jones, 1998). We suggest that
ORF2 N-terminal sequences contain important functions for
certain aspects of the latency-reactivation cycle and that the
respective ORF2 isoforms have slightly different functional
properties. Support for this prediction comes from the ﬁnding
that the ORF2-ORF1 fusion protein encoded by an alternatively
spliced cDNA detected in TG at 7 days after infection interacted
Fig. 3. The 15d ORF stimulates neurite formation in Neuro-2A cells transfected with Notch3. Panel A: Neuro-2A cells were co-transfected with 1 μg plasmid expressing
Notch3 ICD, 1 μg plasmid expressing ORF2 or the 15d ORF, and 1 μg plasmid expressing the Lac Z gene (transfection control). To induce neurite sprouting, 24 h after
transfection cells were seeded into new plates at a low density (2000 cells/cm2) and then starved in media with 0.5% serum for 3 days. Cells were then ﬁxed and β-galþcells
identiﬁed as described in the materials and methods. Panel B: The percent of β-galþcells containing neurites was calculated by dividing the number of β-galþcells with a
neurite length at least twice the diameter of the cell by the total number of β-galþcells. The average of 3 independent experiments is shown with the respective standard
deviation. An asterisk denotes signiﬁcant differences (Po0.05) in β-galþNeuro-2A cells containing neurites following cotransfection with the ORF2 reporter and a Notch1 or
Notch3 expression plasmid relative to β-galþNeuro-2A cells with neurites following transfection with a plasmid expressing Notch1 or Notch3 plus empty vector, as
determined by the One-way ANOVA and Fisher's LSD multiple means comparison tests.
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with C/EBP-alpha (Meyer et al., 2007b), but ORF2 does not.
Although a previous study demonstrated that the 15d ORF
inhibits cold-shock induced apoptosis in Neuro-2A cells with
similar efﬁciency as ORF2 (Shen and Jones, 2008), it was of
interest to compare the other known biological properties of
these two proteins. None of the LR-RNA spliced isoforms that
were identiﬁed can express an intact ORF1. Since ORF1 is
detected in latently infected neurons (Meyer et al., 2007a), we
Fig. 4. The 15d ORF interferes with Notch3 mediated trans-activation of the HES5 promoter. Panel A: Neuro-2A cells were co-transfected with a plasmid containing the
Fireﬂy luciferase gene downstream of the HES5 promoter, a plasmid expressing Notch3 ICD and a plasmid expressing ORF2 or the 15d ORF. As a control, the HES5 promoter
was transfected with an empty vector (pCMV-Tag2B) plus Notch3 ICD to demonstrate the effect that Notch3 ICD has on promoter activity. Panel B: Neuro-2A cells were
cotransfected with a plasmid containing the Fireﬂy luciferase gene downstream of the HES5 promoter, a plasmid expressing Notch3 ICD, and a plasmid expressing the 15d
ORF or the respective mutants derived from the 15d ORF. As a control, the Notch3 ICD was cotransfected with an empty vector. 48 h after transfection promoter activity was
measured using a dual luciferase assay. A plasmid expressing Renilla luciferase under control of a minimal herpesvirus TK promoter was used as an internal control. The
results are the average of four independent experiments and the error bars denote standard deviation. An asterisk for Panel A denotes signiﬁcant differences (Po0.05) in
HES5 promoter activation by Notch3 in the presence of empty vector or WT ORF2 and 15d ORF, as determined by the Student t test. In Panel B, the asterisk denotes signiﬁcant
differences (Po0.05) in HES5 promoter activation by Notch3 in the presence of WT 15d ORF or the indicated 15d ORF transposon mutants.
Notch3 Merge 
Notch3 15d ORF Merge 
Notch3 Merge ORF2 
Fig. 5. The 15d ORF re-localizes Notch3 in transfected Neuro-2A cells. Neuro-2A cells were transfected with Notch3 ICD (Panel A), Flag-tagged ORF2 and the Notch3 ICD
(Panel B), or Notch3 ICD and the 15d ORF plus empty vector (Panel C). Cultures were prepared for confocal microscopy at 48 h after transfection as described in the materials
and methods. Cells were stained with anti-Flag antibody (red), Notch3 antibody (green) or DAPI (blue) to visualize ORF2, Notch3 and the nucleus respectively.
DIC (differential interference contrast) was used to show the unstained cells. The images are representative of 6 experiments.
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suggest that low levels of un-spliced LR-RNA are expressed.
The function of ORF1 is unknown; however, it does not inhibit
apoptosis or interfere with Notch-mediated signaling (Sinani,
unpublished results).
ORF2 and the 15d ORF have three functions that are predicted to
play a role in the establishment and/or maintenance of latency.
First, both proteins inhibit apoptosis (Ciacci-Zanella et al., 1999;
Shen and Jones, 2008; Sinani and Jones, 2011). Secondly, both
proteins interfere with Notch1 and Notch3 mediated transcription,
in part, by interacting with these proteins. Thirdly, the ability of
ORF2 to promote neurite growth in the presence of Notch (Sinani
et al., 2013) may restore normal neuronal functions following
infection. Most ORF2 transposon mutants tested inhibited trans-
activation of the Hes5 promoter whereas ﬁve out of the nine-
transposon mutants of the 15d ORF were inactive. For example, two
ORF2 transposon mutants at position 95 and 134 inhibited Notch1
or Notch3 mediated trans-activation of the HES5 promoter with
similar efﬁciency as wt ORF2 (Sinani et al., 2013). Conversely, two
15d ORF transposon mutants near the amino-terminus, 15d-119 and
15d-159, were unable to inhibit Notch3 mediated trans-activation
of the HES5 promoter. Furthermore, the 15d-P mutant, but not
ORF2-P mutant (Sinani et al., 2013), inhibited Notch3 mediated
trans-activation of the HES5 promoter. Although these differences
appear to be inconsistent with each other, the replacement of
32 C-terminal ORF2 amino acids with 36 amino acids derived from
RF-B may regulate interactions with Notch3 or other Notch family
members. Notch mediated trans-activation is complicated because
it is controlled by interactions between RBP-Jκ (a sequence speciﬁc
DNA binding protein), Mastermind, and other RNA polII transcrip-
tion factors (P300/CBP, P/CAF, and GCN5 for example), reviewed in
Borggrefe and Oswald (2009), Bray (2006) and Ehebauer et al.
(2006). Consequently, it is conceivable that ORF2 and the 15d ORF
have different afﬁnities for Notch family members or their interac-
tions with Notch inﬂuenced the association of Notch with other
transcription factors. The enhanced stability of the 15d ORF is
predicted to have biological signiﬁcance because at 15 days after
infection, the establishment of latency and repair of infected
neurons, as a result of infection, would be important. Expressing a
protein that is more stable, but has similar biological properties as
ORF2, would appear to be advantageous during the transition from
acute infection to establishment of latency.
Materials and methods
Cells
Murine neuroblastoma cells (Neuro-2A) were grown in Earle’s
modiﬁed Eagle’s medium (EMEM) supplemented with 5% FCS,
penicillin (10 U/ml), and streptomycin (100 μg/ml). The designated
ORF2 or 15d ORF expression construct was transfected into Neuro-
2A cells using TransIT-Neural (Mirus, Madison, WI), according to
manufacturer’s instructions. At 24 h after transfection, certain
cultures were treated with 100 μg/ml cycloheximide in EMEM at
37 1C.
ORF2 expression constructs and mutants used in this study
The mammalian 15 dpi cDNA ORF expression construct was
generated in the vector pCMV-Tag-2B (Stratagene). A Flag epitope
is at the N-terminus of the ORF and the human IE CMV promoter
drives its expression. The 15d-P mutant contains alanine substitu-
tions in consensus cAMP-dependent protein kinase A (PKA) and/or
the serine/threonine-speciﬁc protein kinase C (PKC) (Ser31, Thr40,
Ser71, and Ser121). The 15d-P mutant also contains alanine
substitutions in Tyr39 and Ser120, which are adjacent to the
consensus PKA/PKC sites. This mutant was synthesized by IDT
(Coralville, IA) and ligated into the pCMV-Tag-2B at the unique
BamHI-HindIII restriction enzyme sites.
Transposon mutants of the 15d ORF were prepared as pre-
viously described (Sinani and Jones, 2011) (see Fig. 1C for location
of the transposon insertions). In brief, a 57 base pair linker was
randomly inserted into the 15d ORF DNA sequences according to
the manufacturer’s instructions (Epicentre Cat # EZ104KN). The
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Fig. 6. DNA binding properties of the 15d ORF. Neuro-2A cells (5106) were transfected with plasmids expressing the 15d ORF (Panel A), the 15d-P mutant (Panel B), or the
ORF2P mutant (Panel C). DNA chromatography was performed as described in the materials and methods with ss-DNA, ds-DNA, or blank cellulose beads. 1 mg for 15d ORF,
300 μg for 15d-P and 100 μg for ORF2-P mutant of cell extract were used from cells to incubate with DNA cellulose. 10% of the total cell extract used to verify that ORF2 was
expressed (lanes denoted Input). Expression of the 15d ORF, 15d-P, or ORF2-P in Neuro-2A cells was analyzed by Western blots using an anti-Flag antibody. An arrow denotes
ORF2 speciﬁc bands and position of molecular weight standards is denoted.
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site of a transposon insertion was determined by DNA sequencing
and the respective inserts re-cloned into the pCMV2B Flag-tagged
vector at the BamHI-Sal site. The Flag-tagged mutant constructs
were conﬁrmed by sequencing. Each transposon mutation
expresses a full-length 15d ORF with a 19 amino acid transposon
insertion in frame with the ORF.
Western blot analysis
Neuro-2A cells in 60 mm dishes were transfected with the
designated plasmids. 48 h after transfection cells were collected,
washed once with PBS, lysed in RIPA buffer (50 mM Tris–HCl, pH
8150 mMNaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS)
with protease and phosphatase inhibitors (Thermo-Scientiﬁc). The
respective samples were boiled in Laemmli sample buffer for 5 min
and all samples were separated on a 12% SDS–polyacrylamide gel.
Immunodetection of ORF2, the 15d ORF, and the designated 15d ORF
mutants were performed using a mouse anti-Flag antibody (Sigma
F1804) or the ORF2 polyclonal antibody, which were diluted 1:1000
Open Biosystems, which is now part of Thermo Fisher Scien-
tiﬁc, generated the ORF2 polyclonal antibody. Open Biosystems
predicted that two regions in ORF2 were immune-dominant.
These immune-dominant peptides were synthesized, both pep-
tides were co-injected into two rabbits, the crude sera was
collected, and then ORF2-speciﬁc antibodies were afﬁnity puriﬁed
using both peptides. The location of the two ORF2 peptides is
shown in Fig. 1B, denoted by the gray lines.
DNA binding assays by afﬁnity chromatography
The designated ORF2 or 15d ORF expression construct was
transfected into Neuro-2A. 48 h after transfection, monolayers
were washed twice with cold phosphate-buffered saline, scraped
from plates, and then lysed in cell lysis buffer {20 mM Tris–HCl
(pH7.4), 10 mM MgCl2, 500 mM NaCl, 1 mM EDTA, 1 mM β-
mercaptoethanol, 10% glycerol and 100 mg/ml BSA}. The lysate
was sonicated for 15 s prior to rotating at 4 1C for 30 min. Cell
debris was centrifuged at 46,500g for 15 min. The supernatant was
subsequently desalted against dialysis buffer {20 mM Tris–HCl (pH
7.4), 150 mM NaCl, 1 mM EDTA, 1 mM mercaptoethanol, 10%
glycerol and 100 mg/ml BSA} and then used for DNA chromato-
graphy. ORF2 was detected by Western blot analysis using an anti-
Flag antibody (Sigma, St. Louis, MO).
DNA-cellulose chromatography was performed by incubating
100 mg of ds- or ss-DNA cellulose (Sigma, USA) with 1 mg of
mammalian cell lysate containing 15d ORF, 300 mg for 15d-P or
100 mg for ORF2-P mutant for 16 h at 4 1C in binding buffer
{20 mM Tris–HCl (pH 7.4), 50 mM NaCl, 1 mM β-mecaptoethanol,
1 mM EDTA, 100 mg/ml BSA, 10% glycerol, 1 mM Phenylmethane-
sulfonyl ﬂuoride (PMSF) and 1 protease inhibitor (Roche, USA)}.
After the protein was incubated with the designated DNA cellulose
beads, the beads were washed 5 times in binding buffer containing
125 mM NaCl and bound proteins were eluted with Laemmli
SDS–PAGE buffer. Samples were subjected to electrophoresis by
SDS–PAGE and analyzed by Western blot.
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